Urban M O, Coutinho S V, Gebhart G F
Department of Pharmacology, College of Medicine, The University of Iowa, Iowa City 52242, USA.
Pain. 1999 May;81(1-2):45-55. doi: 10.1016/s0304-3959(98)00265-6.
We have recently reported a model of secondary hyperalgesia in which facilitation of the thermal nociceptive tail-flick reflex following topical mustard oil is largely dependent on descending influences from the rostral ventromedial medulla (RVM). The current study was designed to examine a potential role for excitatory amino acid receptors and nitric oxide in the RVM in modulating this hyperalgesia. Topical application of mustard oil (100%) to the lateral surface of the hind leg of awake rats produced a short-lived (60 min) facilitation of the tail-flick reflex that was dose-dependently attenuated by microinjection of the selective N-methyl-D-aspartate (NMDA) receptor antagonist APV (1-100 fmol) into the RVM. Microinjection of a greater dose of APV (1000 fmol) into the RVM produced a significant inhibition of the tail-flick reflex in the presence, but not absence, of mustard oil. In contrast, microinjection of the non-NMDA receptor antagonist DNQX (10 nmol) into the RVM further enhanced the magnitude and duration of the hyperalgesic response, and produced a facilitation of the tail-flick reflex following injection into the RVM of naive animals. Similar to APV, microinjection of the nitric oxide synthase inhibitor L-NAME (100-1000 nmol) into the RVM attenuated mustard oil hyperalgesia, while the greatest dose (1000 nmol) produced a significant inhibition of the tail-flick reflex in the presence, but not absence, of mustard oil. A role for nitric oxide synthase in the RVM in mustard oil hyperalgesia was further demonstrated by a significant increase in the number of NADPH-d labeled cells in the RVM at the time of maximal hyperalgesia. Involvement of NMDA receptors and nitric oxide in the RVM in descending nociceptive facilitation was supported by the observation that microinjection of either NMDA or the NO* donor GEA 5024 into the RVM of naive animals dose-dependently facilitated the tail-flick reflex. The hyperalgesia produced by NMDA injection into the RVM was blocked by prior intra-RVM injection of either APV or L-NAME. These results support the notion that secondary hyperalgesia produced by mustard oil involves concurrent activation of dominant descending facilitatory, as well as masked inhibitory systems from the RVM. Additionally, the data suggest that descending facilitation involves activation of NMDA receptors and production NO* in the RVM, whereas inhibition involves activation of non-NMDA receptors in the RVM.
我们最近报道了一种继发性痛觉过敏模型,其中局部应用芥子油后热痛觉甩尾反射的易化在很大程度上依赖于延髓头端腹内侧区(RVM)的下行影响。本研究旨在探讨兴奋性氨基酸受体和一氧化氮在RVM中调节这种痛觉过敏的潜在作用。将芥子油(100%)局部应用于清醒大鼠后肢外侧表面,可使甩尾反射产生短暂(60分钟)的易化,而向RVM微量注射选择性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂APV(1-100飞摩尔)可剂量依赖性地减弱这种易化。向RVM微量注射更大剂量的APV(1000飞摩尔),在有芥子油存在时可显著抑制甩尾反射,但在无芥子油时则无此作用。相反,向RVM微量注射非NMDA受体拮抗剂DNQX(10纳摩尔)可进一步增强痛觉过敏反应的幅度和持续时间,并在向未处理动物的RVM注射后产生甩尾反射的易化。与APV类似,向RVM微量注射一氧化氮合酶抑制剂L-NAME(100-1000纳摩尔)可减弱芥子油诱导的痛觉过敏,而最大剂量(1000纳摩尔)在有芥子油存在时可显著抑制甩尾反射,但在无芥子油时则无此作用。在最大痛觉过敏时,RVM中NADPH-d标记细胞数量显著增加,进一步证明了一氧化氮合酶在RVM芥子油痛觉过敏中的作用。向未处理动物的RVM微量注射NMDA或NO供体GEA 5024可剂量依赖性地易化甩尾反射,这一观察结果支持了NMDA受体和一氧化氮参与RVM下行痛觉易化的观点。预先向RVM内注射APV或L-NAME可阻断向RVM注射NMDA所产生的痛觉过敏。这些结果支持这样一种观点,即芥子油产生的继发性痛觉过敏涉及RVM中占主导地位的下行易化系统以及被掩盖的抑制系统的同时激活。此外,数据表明下行易化涉及RVM中NMDA受体的激活和NO的产生,而抑制则涉及RVM中非NMDA受体的激活。